Abstract
BackgroundTumor Treating Fields (TTFields) are a non-invasive, antimitotic cancer therapy. The Phase 2 INNOVATE study demonstrated safety of TTFields/weekly paclitaxel in 31 PROC (platinum-resistant ovarian cancer) patients (Vergote Gyn Onc...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have